Answers are grounded in this paper and cite their sources.
One of the greatest causes of numerous diseases is chronic inflammation such as autoimmune diseases, heart diseases and cancer. The discovery of effective anti-inflammatory agents is an ever-important search in contemporary therapy. Zingiber officinale (ginger) is a well-established medicine with its medicinal properties particularly in the anti-inflammatory effects. This paper applied molecular docking to explore the possibility of Gingerol, a ginger bioactive compound to inhibit the Dual Inhibitor of Leukocyte Proteases Cathepsin G and Chymase (PDB ID: 1T32). The docking outcomes revealed that Gingerol showed a better binding affinity (MolDock score of-94.59) than Aspirin (MolDock score of-81.26), which is a commonly used anti-inflammatory medication. Gingerol contains a greater binding affinity and hydrogen bond interactions (-1.46 vs.-0.27 with Aspirin) which might imply that Gingerol could be an effective anti-inflammatory drug. This experiment will open the way to more experimental research on the validation of Gingerol as a natural add-on or substitute to conventional anti-inflammatory treatment.
No takes yet. Share an insight, caveat, or question.
Mekala et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: